GLP-1 AND DUAL AGONISTS In summary, the research progress of GLP-1 in lipid metabolism shows its potential in the treatment of metabolic disorders such as NAFLD, especially combined with its significant weight loss effect, making the application of GLP-1 in obese patients with NAFLD more worthy of in-depth exploration
Ongoing research is needed to assess potential risks associated with prolonged use, including cardiovascular effects and the development of pancreatitis or pancreatic cancer
The mental fog that accompanies aging, poor sleep, or chronic stress starts lifting
Caution notes If you have kidney disease or have been told to limit protein for medical reasons, check with your healthcare provider before increasing intake significantly
Unfortunately, no
Ultimately, people want to feel good about themselves and not experiencing health conditions like severe depression